These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1643202)

  • 1. Protein S negates the activated protein C inhibitory activity of plasma.
    Jane SM; Hau L; Salem HH
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):257-61. PubMed ID: 1643202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
    Mesters RM; Heeb MJ; Griffin JH
    Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va.
    Mesters RM; Heeb MJ; Griffin JH
    Biochemistry; 1993 Nov; 32(47):12656-63. PubMed ID: 8251484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol enhances phospholipid-dependent activated protein C anticoagulant activity.
    Pecheniuk NM; Deguchi H; Griffin JH
    J Thromb Haemost; 2005 Feb; 3(2):340-5. PubMed ID: 15670041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
    Hockin MF; Kalafatis M; Shatos M; Mann KG
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO; Kalafatis M; Mann KG
    Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
    Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
    Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
    Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
    J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of activated protein C by platelets.
    Jane SM; Mitchell CA; Hau L; Salem HH
    J Clin Invest; 1989 Jan; 83(1):222-6. PubMed ID: 2910909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.
    Bakker HM; Tans G; Janssen-Claessen T; Thomassen MC; Hemker HC; Griffin JH; Rosing J
    Eur J Biochem; 1992 Aug; 208(1):171-8. PubMed ID: 1387359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the anticoagulant activity of protein S by prothrombin.
    Mitchell CA; Jane SM; Salem HH
    J Clin Invest; 1988 Dec; 82(6):2142-7. PubMed ID: 2974048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.
    Petäjä J; Fernández JA; Gruber A; Griffin JH
    J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection.
    Solymoss S; Tucker MM; Tracy PB
    J Biol Chem; 1988 Oct; 263(29):14884-90. PubMed ID: 2971660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
    Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
    Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa.
    van de Poel RH; Meijers JC; Bouma BN
    Thromb Haemost; 2001 May; 85(5):761-5. PubMed ID: 11372664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va.
    Gale AJ; Sun X; Heeb MJ; Griffin JH
    Protein Sci; 1997 Jan; 6(1):132-40. PubMed ID: 9007985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivation.
    Rintelen C; Yegneswaran S; Griffin JH
    Thromb Haemost; 2001 Feb; 85(2):274-9. PubMed ID: 11246547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine inhibits inactivation of factor Va by activated protein C.
    Undas A; Williams EB; Butenas S; Orfeo T; Mann KG
    J Biol Chem; 2001 Feb; 276(6):4389-97. PubMed ID: 11083858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutral glycosphingolipid-dependent inactivation of coagulation factor Va by activated protein C and protein S.
    Deguchi H; Fernández JA; Griffin JH
    J Biol Chem; 2002 Mar; 277(11):8861-5. PubMed ID: 11741960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.